Review: Angiotensin II type 1 receptor blockers: class effects versus molecular effects

by Shin-ichiro Miura, Sadashiva S. Karnik, Keijiro Saku
Published 2011-03-01

Effects of smoking cessation on HDL functionality

by Emi Kawachi, Kohei Takata, Satoshi Imaizumi, Shin-ichiro Miura, Keijiro Saku
Published 2019-10-01

Abilities of candesartan and other AT receptor blockers to impair angiotensin II-induced AT receptor activation after wash-out

by Yoshihiro Kiya, Shin-ichiro Miura, Yoshino Matsuo, Sadashiva S Karnik, Keijiro Saku
Published 2012-03-01

Reassessment of the unique mode of binding between angiotensin II type 1 receptor and their blockers.

by Shin-Ichiro Miura, Naoki Nakao, Hiroyuki Hanzawa, Yoshino Matsuo, Keijiro Saku, Sadashiva S Karnik
Published 2013-01-01

Associations between smoking habits and the presence or severity of coronary stenosis as assessed by coronary computed tomography angiography

by Shin-ichiro Miura, Masaya Yano, Yoshiaki Idemoto, Kohei Tashiro, Keijiro Saku, Yuhei Shiga
Published 2019-10-01

Effect of fixed-dose losartan/hydrochlorothiazide on brain natriuretic peptide in patients with hypertension

by Yuhei Shiga, Shin-ichiro Miura, Ryoko Mitsutake, Yoshinari Uehara, Asao Inoue, Keijiro Saku
Published 2012-03-01

Ability of the new AT receptor blocker azilsartan to block angiotensin II-induced AT receptor activation after wash-out

by Shin-ichiro Miura, Yoshino Matsuo, Asuka Nakayama, Sayo Tomita, Yasunori Suematsu, Keijiro Saku
Published 2014-03-01

Constitutively Active Mutant N111G of Angiotensin II Type 1 (AT1) Receptor Induces Homologous Internalization Through Mediation of AT1-Receptor Antagonist

by Mohiuddin Ahmed Bhuiyan, Murad Hossain, Shin-ichiro Miura, Takashi Nakamura, Masanobu Ozaki, Takafumi Nagatomo
Published 2009-01-01

The Effects of Long-Term Nutrition Counseling According to the Behavioral Modification Stages in Patients with Cardiovascular Disease

by Keiko Matsuzaki, Nobuko Fukushima, Yutaka Saito, Naoya Matsumoto, Mayu Nagaoka, Yousuke Katsuda, Shin-ichiro Miura
Published 2021-01-01

Associations between High-Density Lipoprotein Functionality and Major Adverse Cardiovascular Events in Patients Who Have Undergone Coronary Computed Tomography Angiography

by Hiroko Inoue, Yuhei Shiga, Kenji Norimatsu, Kohei Tashiro, Makito Futami, Yasunori Suematsu, Makoto Sugihara, Hiroaki Nishikawa, Yousuke Katsuda, Shin-ichiro Miura
Published 2021-05-01

Significance of pigment epithelium-derived factor levels with angiotensin II type 1 receptor blockers in patients with successful coronary stent implantation

by Makoto Sugihara, Shin-ichiro Miura, Yosuke Takamiya, Yoshihiro Kiya, Tadaaki Arimura, Atsushi Iwata, Akira Kawamura, Hiroaki Nishikawa, Sho-ichi Yamagishi, Keijiro Saku
Published 2011-09-01

Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study

by Bo Zhang, Akira Matsunaga, David L. Rainwater, Shin-ichiro Miura, Keita Noda, Hiroaki Nishikawa, Yoshinari Uehara, Kazuyuki Shirai, Masahiro Ogawa, Keijiro Saku
Published 2009-09-01

Comparison of the Effects of Na+ and K+ Channel Blockers on the Electrophysiological Properties of the Pulmonary Veins in Patients with Atrial Fibrillation

by Tomoo Yasuda, MD, Koichiro Kumagai, MD, Masahiro Ogawa, MD, Hideko Nakashima, MD, Bo Zhang, PhD, Shin-ichiro Miura, MD, Keijiro Saku, MD
Published 2010-01-01

A Woman With Hypertriglyceridemia Who Acquired Antibody Against GPIHBP1

by Yuka Hirano, MD, Yasunori Suematsu, MD, PhD, Yuiko Yano, MD, PhD, Shuichi Sato, MD, PhD, Shin-Ichiro Miura, MD, PhD
Published 2020-01-01

Correction: Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor

by Shin-ichiro Miura, Yoshihiro Kiya, Hiroyuki Hanzawa, Naoki Nakao, Masahiro Fujino, Satoshi Imaizumi, Yoshino Matsuo, Hiroaki Yanagisawa, Hiroyuki Koike, Issei Komuro, Sadashiva S. Karnik, Keijiro Saku
Published 2013-01-01

Small molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptor.

by Shin-ichiro Miura, Yoshihiro Kiya, Hiroyuki Hanzawa, Naoki Nakao, Masahiro Fujino, Satoshi Imaizumi, Yoshino Matsuo, Hiroaki Yanagisawa, Hiroyuki Koike, Issei Komuro, Sadashiva S Karnik, Keijiro Saku
Published 2012-01-01

Correction: Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor.

by Shin-ichiro Miura, Yoshihiro Kiya, Hiroyuki Hanzawa, Naoki Nakao, Masahiro Fujino, Satoshi Imaizumi, Yoshino Matsuo, Hiroaki Yanagisawa, Hiroyuki Koike, Issei Komuro, Sadashiva S. Karnik, Keijiro Saku
Published 2013-01-01

Comparison of clinical outcomes between patients with pulseless-ventricular tachycardia and ventricular fibrillation in out-of-hospital cardiac arrest

by Yuta Kato, Shin-ichiro Miura, Atsushi Hirayama, Chisato Izumi, Satoshi Yasuda, Yoshio Tahara, Naohiro Yonemoto, Hiroshi Nonogi, Ken Nagao, Takanori Ikeda, Naoki Sato, Hiroyuki Tsutsui, Yoshio Kobayashi
Published 2021-06-01

Efficacy and safety of combination therapy of high-dose losartan and hydrochlorothiazide in patients with hypertension

by Yuhei Shiga, Shin-ichiro Miura, Kenji Norimatsu, Yuka Hitaka, Itsuki Nagata, Rie Koyoshi, Joji Morii, Takashi Kuwano, Yoshinari Uehara, Asao Inoue, Tetsuro Shirotani, Kazuaki Fujisawa, Eiyu Matsunaga, Keijiro Saku
Published 2015-12-01

Assessment of various parameters using simple non-invasive tests in patients with cardiovascular diseases with or without cardiac rehabilitation

by Takashi Ueda, Shin-ichiro Miura, Kanta Fujimi, Toshihisa Ishida, Takuro Matsuda, Masaomi Fujita, Yoshiyuki Ura, Kouji Kaino, Maya Sakamoto, Tomoe Horita, Tadaaki Arimura, Yuhei Shiga, Takashi Kuwano, Ken Kitajima, Keijiro Saku
Published 2016-09-01